Industry News

Nov 10, 2017
By BioPharm International Editors
Two of the medicines recommended for approval are orphan drugs.
Nov 09, 2017
By BioPharm International Editors
FDA is exploring ways to keep branded drug companies from using REMS to block the development of generic drugs.
Nov 07, 2017
By BioPharm International Editors
While most pharma companies are in partial production using generators, few are operating at 100% capacity.
Nov 07, 2017
By BioPharm International Editors
The debate continues over biosimilar naming, interchangeability, and patent protection, as well as lingering concerns in the medical community about the safety of switching patients to new therapies.
Nov 06, 2017
By BioPharm International Editors
The voluntary recall is due to blister packages containing the incorrect product.
Nov 03, 2017
By BioPharm International Editors
FDA sent warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these statements.
Nov 03, 2017
By BioPharm International Editors
The Human Vaccines Project has created the Universal Influenza Vaccine Initiative, a research program that will aim to understand the human immune system’s role in the development of universal influenza vaccines.
Nov 03, 2017
By BioPharm International Editors
The agency gave Breakthrough Therapy Designation to GSK’s GSK2857916 monotherapy for the treatment of patients with multiple myeloma who have failed at least three prior lines of therapy.
Oct 31, 2017
By BioPharm International Editors
A mutual recognition agreement to accept inspection data from eight EU regulatory authorities may reduce inspection burdens at global drug facilities.
Oct 26, 2017
By BioPharm International Editors
The new BioLive event, which will be a global hub for biopharmaceutical manufacturing, will launch alongside CPhI Worldwide 2018 in Madrid.
native1_300x100
lorem ipsum